{
    "nct_id": "NCT04257617",
    "official_title": "First in Human, Phase I Trial of ZL-1201 in Subjects With Advanced Cancer",
    "inclusion_criteria": "* Histologically/cytologically confirmed, locally advanced unresectable or metastatic solid tumors and lymphomas that are refractory or intolerant to standard of care therapy, or for which no standard therapy exists.\n* Adequate hematologic status\n* Adequate coagulation function\n* Adequate hepatic function\n* Adequate renal function\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Known active brain metastases\n* Red blood cells transfusion dependence\n* Known cardiopulmonary disease\n* Pregnant or breast-feeding females\n* Any other serious underlying medical",
    "miscellaneous_criteria": ""
}